```html

Zee Disease (Capgras Syndrome) – A Patient‑Friendly Guide

Overview

Capgras syndrome, sometimes referred to in popular media as “Zee disease,” is a delusional misidentification disorder in which the affected person firmly believes that a familiar person—most often a spouse, parent, or close friend—has been replaced by an identical imposter. The condition can also involve objects, places, or pets.

The syndrome is named after French psychiatrist Joseph Capgras, who first described it in 1923. It is classified under delusional misidentification syndromes in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM‑5).

Who is affected?

• Adults aged 45–80 are the most commonly reported group.
• Both men and women are affected, with a slight preponderance in males (≈55%).
• The disorder is rare in children, but it can appear in adolescents with severe neurodevelopmental disorders.

Prevalence

Exact prevalence is difficult to determine because Capgras syndrome often occurs alongside other neurological or psychiatric illnesses. Estimates suggest:

• 0.5–1.0 % of patients with schizophrenia.
• 5–15 % of individuals with neurodegenerative diseases such as Alzheimer’s or Lewy body dementia.<sup>[1] Mayo Clinic</sup>
• Overall, fewer than 1 in 20,000 people in the general population are diagnosed with an isolated form of the syndrome.

Symptoms

Symptoms can be grouped into core delusional beliefs, associated psychiatric/neurological features, and behavioral consequences.

Core Delusional Beliefs

• Imposter belief: Conviction that a familiar person has been replaced by a duplicate who looks identical but is “not the real” individual.
• Extension to objects or places: Some patients think their home, car, or cherished belongings have been swapped.
• Persistence: The belief is usually fixed and resistant to logical evidence.

Associated Psychiatric/Neurological Features

• Paranoia or suspicion toward the perceived imposter.
• Grounded anxiety or fear that the impostor will cause harm.
• Hallucinations (visual or auditory) in a minority of cases, especially when the syndrome co‑exists with schizophrenia.
• Memory deficits, especially for recent events (common in dementia‑related cases).
• Disorientation to time or place in advanced neurodegenerative disease.

Behavioral Consequences

• Avoidance or aggression toward the “imposter.”
• Repeated questioning of the person’s identity.
• Social withdrawal, which can worsen caregiver stress.
• In severe cases, attempts to “protect” the patient from the imagined impostor, leading to restrictive measures.

Causes and Risk Factors

Capgras syndrome is not a disease itself but a symptom of underlying brain dysfunction. The precise mechanism is still being researched, but two major pathways have emerged.

Neurobiological Theories

1. Disconnection hypothesis: Damage to the pathways linking facial recognition (temporal‑occipital cortex) with emotional processing (amygdala) creates a “recognition without feeling” state, prompting the brain to generate a delusional explanation.<sup>[2] CDC</sup>
2. Right‑hemisphere dysfunction: Lesions in the right frontal or temporal lobes disrupt self‑monitoring and reality testing, which are essential for accurate identification.

Underlying Conditions Frequently Associated

• Neurodegenerative diseases – Alzheimer’s, Lewy body dementia, frontotemporal dementia.
• Psychiatric disorders – Schizophrenia, bipolar disorder with psychotic features.
• Brain injury – Traumatic brain injury (TBI), stroke, especially in the right hemisphere.
• Infections – Creutzfeldt‑Jakob disease, HIV‑associated neurocognitive disorder.
• Epilepsy – Particularly temporal‑lobe epilepsy.

Risk Factors

• Age > 50, because neurodegenerative diseases become more common.
• History of psychiatric illness (especially psychosis).
• Prior head trauma or cerebrovascular accident.
• Genetic predisposition to dementia or schizophrenia.

Diagnosis

Diagnosing Capgras syndrome involves a thorough clinical interview, collateral information from family/caregivers, and targeted investigations to uncover the underlying cause.

Clinical Evaluation

1. History taking: Onset, progression, and triggers of the delusional belief; past psychiatric or neurological diagnoses; medication review.
2. Mental status exam: Assess orientation, attention, memory, insight, and presence of other psychotic symptoms.
3. Collateral interview: Family members often provide the clearest description of behavioral changes.

Neuroimaging

• MRI of the brain: Detects atrophy, ischemic lesions, or tumors, especially in the right frontal/temporal regions.
• CT scan: Useful in acute settings or when MRI is contraindicated.
• FDG‑PET or SPECT: May reveal hypometabolism in temporoparietal or frontal networks in dementia‑related cases.

Laboratory Tests

• Complete blood count, metabolic panel – rule out metabolic encephalopathies.
• Thyroid function, vitamin B12 – deficiencies can mimic psychiatric symptoms.
• Serology for HIV, syphilis, or other infectious agents if clinically indicated.

Neuropsychological Testing

Standardized batteries (e.g., MoCA, MMSE) help quantify cognitive deficits and track progression.

Differential Diagnosis

• Other delusional misidentification syndromes (Fregoli, intermetamorphosis).
• Primary psychotic disorders without neurological disease.
• Severe anxiety or obsessive‑compulsive disorder with intrusive thoughts.

Treatment Options

Because Capgras syndrome is a symptom rather than a stand‑alone disease, treatment targets the underlying condition and the delusional belief itself.

Pharmacologic Therapies

1. Antipsychotics: First‑line for psychosis. Options include:
   • Risperidone 0.5–4 mg daily
   • Olanzapine 5–15 mg daily
   • Quetiapine 50–300 mg nightly (especially useful when sedation is desired)
   Side‑effects (weight gain, metabolic syndrome) should be monitored.<sup>[3] Cleveland Clinic</sup>
2. Cholinesterase inhibitors: For Alzheimer’s‑related cases, donepezil 5–10 mg daily can modestly improve cognition and may reduce delusional intensity.
3. NMDA‑antagonists: Memantine (10 mg BID) is sometimes added in moderate‑to‑severe dementia.
4. Mood stabilizers: Valproic acid or lamotrigine may be useful when mood swings accompany the delusion.

Non‑pharmacologic Strategies

• Cognitive‑behavioral therapy (CBT): Tailored to reality‑orientation and “re‑framing” the imposter belief, though effectiveness is limited when insight is absent.
• Reality‑orientation cues: Use of photos, name tags, and routine schedules to reinforce familiarity.
• Environmental modifications: Quiet, well‑lit rooms; minimizing mirrors and reflective surfaces that can trigger confusion.
• Family education & support: Teaching caregivers how to respond calmly, avoid confrontation, and use validation techniques.

Procedural Interventions

In rare, refractory cases, electroconvulsive therapy (ECT) has shown benefit, especially when the syndrome is linked to severe depression or catatonia. ECT should be performed only after multidisciplinary review.

Lifestyle & Supportive Care

• Regular aerobic exercise (30 min most days) can improve cerebral blood flow.<sup>[4] NIH</sup>
• Balanced diet rich in omega‑3 fatty acids, antioxidants, and B‑vitamins.
• Adequate sleep hygiene—7–9 hours per night.
• Social engagement through support groups or day programs to reduce isolation.

Living with Zee disease (Capgras syndrome)

Managing day‑to‑day life requires cooperation between the patient, family, and health‑care team.

Practical Tips for Caregivers

1. Stay calm and avoid arguing: Direct confrontation often worsens agitation.
2. Use validation: Acknowledge the person’s feelings (“I see this is frightening for you”) before gently guiding them to reality.
3. Maintain routines: Predictable daily schedules reduce confusion.
4. Label personal items: Name tags on clothing, photographs labeled with names and dates placed in common areas.
5. Safety planning: Remove sharp objects if aggression is present; consider a medical alert bracelet indicating the diagnosis.

Patient‑Focused Strategies

• Keep a daily journal of “what feels real” to help a therapist track thought patterns.
• Engage in reality‑checking exercises with a trusted family member (e.g., looking at a photo together and naming the relationship).
• Practice relaxation techniques—deep breathing, progressive muscle relaxation—to curb anxiety.

Support Resources

• Alzheimer’s Association (www.alz.org) – caregiver webinars.
• National Alliance on Mental Illness (NAMI) – local support groups.
• Psychiatric Rehabilitation Services – community‑based occupational therapy.

Prevention

Because the syndrome itself cannot be prevented, efforts focus on reducing the risk of the underlying diseases that trigger it.

Neuroprotective Measures

• Control vascular risk factors – hypertension, diabetes, hyperlipidemia (target BP < 130/80 mmHg, HbA1c < 7%).
• Engage in lifelong learning and cognitively stimulating activities (e.g., puzzles, language classes).
• Avoid head trauma – wear helmets while cycling, use seat belts.
• Limit alcohol intake to ≤ 2 drinks/day for men, ≤ 1 drink/day for women.

Psychiatric Prevention

• Early treatment of psychosis or mood disorders reduces the chance of chronic delusional states.
• Regular medication adherence and follow‑up appointments.
• Screen for depression and anxiety in patients with early cognitive decline.

Complications

If left untreated, Capgras syndrome can lead to serious physical, mental, and social complications.

• Physical injury: Aggressive attempts to “protect” themselves from an imagined impostor can cause falls or self‑harm.
• Social isolation: Withdrawal may result in loss of support networks, accelerating cognitive decline.
• Caregiver burnout: Persistent suspicion and conflict increase stress, depression, and risk of institutionalization.
• Progression of underlying disease: Unmanaged dementia or schizophrenia can worsen overall prognosis.
• Legal issues: In extreme cases, patients may file lawsuits or make false accusations based on the delusion.

When to Seek Emergency Care

---

References:

1. Mayo Clinic. “Capgras syndrome.” Accessed May 2024. https://www.mayoclinic.org/diseases-conditions/capgras-syndrome
2. Centers for Disease Control and Prevention. “Delusional Misidentification Syndromes: Neurocognitive Mechanisms.” 2023.
3. Cleveland Clinic. “Antipsychotic Medications: Uses, Side Effects, and Risks.” Updated 2024.
4. National Institutes of Health. “Physical Activity and Brain Health.” 2022.

```